Total Payments
$45,464
2024 Payments
$542.96
Companies
21
Transactions
47
Medicare Patients
1,807
Medicare Billing
$201,626
Payment Breakdown by Category
Consulting$36,176 (79.6%)
Other$8,088 (17.8%)
Food & Beverage$798.00 (1.8%)
Education$327.20 (0.7%)
Travel$75.28 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $36,176 | 19 | 79.6% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,038 | 2 | 13.3% |
| Honoraria | $2,050 | 2 | 4.5% |
| Food and Beverage | $798.00 | 13 | 1.8% |
| Education | $327.20 | 8 | 0.7% |
| Travel and Lodging | $75.28 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $17,873 | 16 | $0 (2024) |
| GENZYME CORPORATION | $6,388 | 2 | $0 (2020) |
| Verastem, Inc. | $6,062 | 2 | $0 (2019) |
| Karyopharm Therapeutics Inc. | $2,250 | 1 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $2,089 | 4 | $0 (2018) |
| Celgene Corporation | $2,001 | 2 | $0 (2020) |
| Janssen Biotech, Inc. | $1,768 | 1 | $0 (2022) |
| Dendreon Pharmaceuticals LLC | $1,635 | 2 | $0 (2019) |
| Secura Bio, Inc. | $1,598 | 2 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $1,515 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $542.96 | 3 | AstraZeneca Pharmaceuticals LP ($525.00) |
| 2023 | $2,662 | 6 | AstraZeneca Pharmaceuticals LP ($2,498) |
| 2022 | $6,382 | 6 | Janssen Biotech, Inc. ($1,768) |
| 2021 | $6,593 | 6 | AstraZeneca Pharmaceuticals LP ($4,271) |
| 2020 | $12,777 | 8 | AstraZeneca Pharmaceuticals LP ($6,516) |
| 2019 | $14,390 | 12 | Verastem, Inc. ($6,062) |
| 2018 | $2,089 | 4 | Takeda Pharmaceuticals U.S.A., Inc. ($2,089) |
| 2017 | $28.65 | 2 | Merck Sharp & Dohme Corporation ($17.75) |
All Payment Transactions
47 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Consulting Fee | Cash or cash equivalent | $525.00 | General |
| Category: Oncology | ||||||
| 01/30/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $3.33 | General |
| Category: ONCOLOGY | ||||||
| 01/11/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $14.63 | General |
| 12/26/2023 | AstraZeneca Pharmaceuticals LP | ENHERTU (Biological) | Consulting Fee | Cash or cash equivalent | $1,387.50 | General |
| Category: Oncology | ||||||
| 11/22/2023 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| Category: Oncology | ||||||
| 07/01/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: ONCOLOGY | ||||||
| 03/10/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2023 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.99 | General |
| 02/22/2023 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2022 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,110.00 | General |
| Category: Oncology | ||||||
| 10/25/2022 | Janssen Scientific Affairs, LLC | IMBRUVICA (Drug) | Consulting Fee | Cash or cash equivalent | $1,515.00 | General |
| Category: Oncology | ||||||
| 10/06/2022 | Daiichi Sankyo Inc. | — | Honoraria | Cash or cash equivalent | $550.00 | General |
| 05/20/2022 | SANOFI-AVENTIS U.S. LLC | ELITEK (Biological) | Education | In-kind items and services | $89.99 | General |
| Category: Oncology | ||||||
| 04/13/2022 | BeiGene USA, Inc. | BRUKINSA (Drug) | Consulting Fee | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 03/16/2022 | Janssen Biotech, Inc. | DARZALEX (Biological) | Consulting Fee | Cash or cash equivalent | $1,767.50 | General |
| Category: Oncology | ||||||
| 12/14/2021 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $108.27 | General |
| Category: Oncology | ||||||
| 10/08/2021 | Pharmacyclics LLC, An AbbVie Company | IMBRUVICA (Drug) | Education | In-kind items and services | $60.99 | General |
| Category: ONCOLOGY | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,497.50 | General |
| Category: Oncology | ||||||
| 05/25/2021 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| Category: Oncology | ||||||
| 03/18/2021 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | In-kind items and services | $11.04 | General |
| Category: Oncology | ||||||
| 03/14/2021 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| 12/10/2020 | GENZYME CORPORATION | SARCLISA (Biological) | Consulting Fee | Cash or cash equivalent | $2,685.00 | General |
| Category: Oncology | ||||||
| 09/23/2020 | Celgene Corporation | Pomalyst (Drug), Revlimid | Consulting Fee | Cash or cash equivalent | $1,977.50 | General |
| Category: Hematology | ||||||
| 09/15/2020 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $108.27 | General |
| Category: Oncology | ||||||
| 08/05/2020 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $1,665.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 471 | 808 | $191,731 | $62,030 |
| 2022 | 9 | 447 | 741 | $157,262 | $52,791 |
| 2021 | 8 | 463 | 694 | $141,612 | $47,900 |
| 2020 | 9 | 426 | 692 | $136,266 | $38,905 |
Total Patients
1,807
Total Services
2,935
Medicare Billing
$201,626
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 90 | 293 | $84,816 | $30,333 | 35.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 123 | 175 | $37,870 | $11,248 | 29.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 71 | 137 | $26,371 | $8,323 | 31.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 100 | 111 | $16,047 | $4,537 | 28.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 33 | $11,564 | $3,297 | 28.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $6,577 | $2,000 | 30.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $3,834 | $1,031 | 26.9% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 12 | 12 | $3,263 | $765.12 | 23.4% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 11 | 13 | $1,389 | $495.95 | 35.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 56 | 165 | $45,520 | $17,343 | 38.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 108 | 160 | $32,800 | $10,815 | 33.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 162 | $29,970 | $8,854 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 114 | 137 | $18,769 | $6,289 | 33.5% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 38 | 42 | $14,112 | $4,335 | 30.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,728 | $1,713 | 36.2% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 19 | 19 | $4,731 | $1,474 | 31.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 21 | 21 | $4,263 | $1,283 | 30.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 19 | 23 | $2,369 | $685.32 | 28.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 37 | 108 | $29,808 | $11,334 | 38.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 149 | $30,545 | $10,722 | 35.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 78 | 166 | $30,710 | $9,333 | 30.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 137 | 154 | $21,098 | $7,118 | 33.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 31 | 33 | $11,088 | $3,510 | 31.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 29 | 29 | $9,048 | $3,007 | 33.2% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 24 | 25 | $6,225 | $1,975 | 31.7% |
About Dr. Dhaval Mehta, M.D
Dr. Dhaval Mehta, M.D is a Internal Medicine healthcare provider based in Monroeville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/15/2008. The National Provider Identifier (NPI) number assigned to this provider is 1902060312.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Dhaval Mehta, M.D has received a total of $45,464 in payments from pharmaceutical and medical device companies, with $542.96 received in 2024. These payments were reported across 47 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($36,176).
As a Medicare-enrolled provider, Mehta has provided services to 1,807 Medicare beneficiaries, totaling 2,935 services with total Medicare billing of $201,626. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Monroeville, PA
- Active Since 07/15/2008
- Last Updated 01/14/2014
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902060312
Products in Payments
- CALQUENCE (Drug) $11,125
- Copiktra (Drug) $6,062
- ELITEK (Drug) $3,703
- IMFINZI (Drug) $3,062
- SARCLISA (Biological) $2,685
- XPOVIO (Drug) $2,250
- NINLARO (Drug) $2,089
- Pomalyst (Drug) $1,978
- DARZALEX (Biological) $1,768
- PROVENGE (Drug) $1,635
- Farydak (Drug) $1,598
- IMBRUVICA (Drug) $1,576
- ENHERTU (Biological) $1,388
- BRUKINSA (Drug) $1,350
- IMFINZI (Biological) $525.00
- TAGRISSO (Drug) $108.27
- ELITEK (Biological) $89.99
- KRAZATI (Drug) $42.00
- XTANDI (Drug) $25.72
- Revlimid (Drug) $23.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Monroeville
Dr. Richard Rosenthal, Md, MD
Internal Medicine — Payments: $7,627
Internal Medicine $7,627
Dr. Francis Colangelo, Md, MD
Internal Medicine — Payments: $3,998
Internal Medicine $3,998
Dr. Kenneth Mcgaffin, Md, MD
Internal Medicine — Payments: $3,737
Internal Medicine $3,737
Dr. Manjusha Rajamohanty, M.d, M.D
Internal Medicine — Payments: $3,729
Internal Medicine $3,729
Dr. Thomas Bonacorsi, M.d, M.D
Internal Medicine — Payments: $3,656
Internal Medicine $3,656
Dr. James Costlow, Md, MD
Internal Medicine — Payments: $3,629
Internal Medicine $3,629